Air travel disruptions add pressure on Congress for shutdown deal
The U.S. air travel disruptions, which hurt both passengers and airlines, are among the most visible examples of how the shutdown is inconveniencing Americans.
The U.S. air travel disruptions, which hurt both passengers and airlines, are among the most visible examples of how the shutdown is inconveniencing Americans.
With the launch of Gemini Enterprise, Google Cloud is directly challenging rivals such as Microsoft’s Copilot and OpenAI’s ChatGPT Enterprise.
More than a quarter of the jobless have been out of work more than a half-year—the highest share since the mid-2010s excluding the pandemic-era years.
Stellantis’ actions would mirror those of companies unveiling big investment plans to curry favor with President Donald Trump and mitigate the impact of tariffs.
Across the college sports ecosystem, universities are under pressure to find new ways to raise revenue, after a landmark federal settlement over student athletes’ name, image and likeness rights opened the door for them to be paid by schools.
Shares in Indianapolis-based Eli Lilly and Co. were on the rise Wednesday after President Trump suggested the company would be next up to cut a deal over drug pricing.
Most industry observers forecast a slowdown in EV sales in the coming quarters, because without the federal incentives, the vehicles are still more expensive than gas-powered cars.
Another report showed consumer confidence fell in September to a five-month low on concerns about a cooling labor market and the broader economy.
While demand is on the rise for carbon-free fission power as the U.S. races to meet a surge in electricity needs, costs remain high and construction is expected to be slow.
The U.S. lowered tariffs on auto imports from the European Union to 15% retroactive to Aug. 1, cementing terms of the framework trade agreement the two sides struck almost two months ago.
Eli Lilly and Co. and Novo Nordisk have been locked in a fierce battle to control the obesity market, which is projected to reach $100 billion by the end of the decade.
The Securities and Exchange Commission has required publicly traded companies to report on a quarterly basis since 1970.
Investors are betting on optimism regarding artificial intelligence and Federal Reserve interest-rate cuts to keep technology stocks moving higher.
The recommendation applies to a range of GLP-1 drugs that also includes Novo Nordisk’s Ozempic and Lilly’s older diabetes treatment, Trulicity.
At the same time, there were a few hopeful signs about the outlook. Orders expanded for the first time since the start of the year.
Eli Lilly and Co. announced this month it would raise the weight-loss treatment’s price by as much as 170%, presenting pharmacies with a dilemma about how much they would pass on to patients.
The summer surge shows how dealmakers have continued their strong recovery from what was a disappointing start to the year.
The company’s shares rose as much as 4.3% Tuesday after Eli Lilly announced the trial results for orforglipron.
Six-year loans, at one time considered the upper end of the range, are now the most common, accounting for 36.1% of loans in the second quarter.
Tighter in-office mandates and the high cost of eating out are driving more workers to corporate cafeterias, where upgraded amenities and better food are used to lure staff back.